Columbia University Medical Center — New York, New York

Public research footprint of Columbia University Medical Center, compiled from the ClinicalTrials.gov public registry.

2,329

Registered studies

598

Active

272

Recruiting now

1,311

Completed

347

Stopped or withdrawn

Most-studied conditions

Unresectable Malignant Solid Neoplasm · Recurrent Astrocytoma, IDH-Mutant, Grade 3 · Metastatic Bladder Large Cell Neuroendocrine Carcinoma · Resectable Pancreatic Ductal Adenocarcinoma (PDAC)

Recently updated registry entries

NCT02196181 — Testing Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer… (Active Not Recruiting)
NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT03528642 — Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Columbia University Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.